RxDoctor Payments DataLook up a doctor →

Cynthia Robbins, MD

Obstetrics & Gynecology · Fort Worth, TXNPI 1538117098

Payments from drug & device makers

$7,804,689in general payments, 2019–2025

Across 1,363 payments — averaging $5726.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$3.6M
  • GSK$2.8M
  • Modernatx, Inc.$1.2M
  • Organon$157K
  • Sanofi US Services Inc.$61K
  • Sanofi Pasteur Inc.$51K
  • plus $47K from 37 others

What the payments were for

  • Consulting fees$10,75062%
  • Travel & lodging$1,2127%
  • Food & beverage$5,13230%
  • Education$1141%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,804,689 in reported general payments places this provider in the 95th percentile of 3,099 obstetrics & gynecology providers in Texas.

See all obstetrics & gynecology providers in Texas

Medicare billing

Part B allowed, 2024
$20,064
Medicare patients
186
Services billed
583

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol140$6,633
ProgesteroneProgesterone, Micronized62$2,138
Tolterodine Tartrate ErTolterodine Tartrate11$1,307
Venlafaxine Hcl ErVenlafaxine Hcl22$1,025
SynthroidLevothyroxine Sodium11$532
Citalopram HbrCitalopram Hydrobromide40$416
ValacyclovirValacyclovir Hcl12$149
Levothyroxine Sodium19$125
Sertraline Hcl15$16

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieSynthroid$1,238$53211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,099 obstetrics & gynecology providers in Texas.

Other obstetrics & gynecology in Fort Worth

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →